REGOLA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 436
EU - Europa 272
AS - Asia 194
OC - Oceania 4
AF - Africa 2
SA - Sud America 2
Totale 910
Nazione #
US - Stati Uniti d'America 435
SG - Singapore 69
IT - Italia 66
HK - Hong Kong 65
DE - Germania 63
CN - Cina 40
FI - Finlandia 33
UA - Ucraina 30
GB - Regno Unito 23
RU - Federazione Russa 21
TR - Turchia 14
IE - Irlanda 13
MK - Macedonia 7
FR - Francia 6
GR - Grecia 4
AU - Australia 3
PH - Filippine 2
SA - Arabia Saudita 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ES - Italia 1
JO - Giordania 1
JP - Giappone 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PE - Perù 1
SE - Svezia 1
UG - Uganda 1
Totale 910
Città #
Fairfield 65
Hong Kong 65
Singapore 60
Ashburn 48
Helsinki 31
Chandler 30
Houston 26
Jacksonville 25
Princeton 25
Woodbridge 23
Cambridge 22
Wilmington 22
Seattle 19
New York 18
Ann Arbor 13
Dublin 13
Istanbul 13
Brescia 10
Beijing 8
San Diego 7
Bergamo 6
Munich 6
Shanghai 5
Bosio 4
Des Moines 4
Moscow 4
Changsha 3
Duncan 3
Falkenstein 3
Melbourne 3
Redwood City 3
Rome 3
Skopje 3
Bagheria 2
Cosenza 2
Haikou 2
Khobar 2
Lappeenranta 2
Lodi 2
London 2
Los Angeles 2
Motta Baluffi 2
Mountain View 2
Nanchang 2
Nürnberg 2
Romola 2
Shenyang 2
Whitley Bay 2
Abidjan 1
Amman 1
Amsterdam 1
Athens 1
Auckland 1
Bari 1
Boardman 1
Buffalo 1
Cagayan de Oro 1
Chicago 1
Corridonia 1
Forlì 1
Genova 1
Gorle 1
Hebei 1
Jiaxing 1
Kunming 1
Lanzhou 1
Lima 1
Madrid 1
Markham 1
Milan 1
Monza 1
Mount Carmel 1
Nanjing 1
Orange 1
Prescot 1
Rivoli 1
San Francisco 1
Soncino 1
Southwark 1
Taiyuan 1
Torino 1
Washington 1
Yurovka 1
Zhengzhou 1
Totale 659
Nome #
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 130
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 117
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 117
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 89
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 85
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 63
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients 56
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 51
Can we use NOACS in APS? 43
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 40
Novel Therapies in Takayasu Arteritis. 28
Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis 26
Tapering belimumab in patients with systemic lupus erythematosus: a single-centre experience 23
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 20
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 18
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 15
Retinal microvascular alterations in patients with active rheumatoid arthritis without cardiovascular risk factors: the potential effects of T cell co-stimulation blockade 11
Totale 932
Categoria #
all - tutte 7.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.017


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 0 0 14 12 13 13 5 11
2020/2021180 7 27 13 23 14 13 7 12 16 25 15 8
2021/2022133 9 16 10 4 4 6 5 11 7 15 21 25
2022/202393 15 1 3 5 10 29 0 10 11 0 6 3
2023/2024162 13 3 21 14 5 30 3 16 35 1 5 16
2024/2025180 7 13 8 51 28 38 35 0 0 0 0 0
Totale 932